← Leaderboards
Lonny R Levin
Weill Medical College Of Cornell Univ
$17,449,947
Attributed
$25,933,119
Total exposure
16
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,896,929 · 18
By mechanism
R01$18,817,627 · 9
P50$18,603,677 · 8
R21$475,625 · 1
Top collaborators
- Jochen Buck38 shared
- Pablo Eduardo Visconti10 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Jochen Buck$16,607,665
Others in their field
Top investigators on “Adenylate Cyclase”
- Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School$15,473,498
- Jochen Buck · Weill Medical College Of Cornell Univ$14,681,913
- Dennis Brown · Massachusetts General Hospital$13,042,858
- Daniel R Storm · University Of Washington$11,877,486
- Pedro A. Jose · George Washington University$10,827,484
- H. Kirk Hammond · University Of California San Diego$9,009,378
Research focus
Adenylate CyclaseBicarbonatesSperm CellCyclic AmpInhibitor/AntagonistKnockout MiceMaleMolecularIn VivoContraceptive AgentsEjaculationResponsePropertyEpididymisSignal TransductionSecond Messenger SystemsPharmacologyBiochemicalGeneticEnzymesMediatingPhysiologyResourcesDesign
Grant awards (69)
On-demand nonhormonal male contraception via ADCY10 inhibition$1,999,520
P50 · FY2025 · HD · contact PI
Comparative studies on the regulation of metabolism during sperm capacitation$694,239
R01 · FY2025 · HD
Optimization of lead candidates for an on-demand male contraceptive$687,095
R01 · FY2025 · HD
Optimization of in vivo validated ADCY10 inhibitors$395,552
P50 · FY2025 · HD · contact PI
Target Engagement$254,570
P50 · FY2025 · HD · contact PI
Administrative Core$251,221
P50 · FY2025 · HD · contact PI
On-demand nonhormonal male contraception via ADCY10 inhibition$1,999,520
P50 · FY2024 · HD · contact PI
Comparative studies on the regulation of metabolism during sperm capacitation$693,491
R01 · FY2024 · HD
Optimization of lead candidates for an on-demand male contraceptive$682,405
R01 · FY2024 · HD
Optimization of in vivo validated ADCY10 inhibitors$395,552
P50 · FY2024 · HD · contact PI
Target Engagement$254,570
P50 · FY2024 · HD · contact PI
Administrative Core$251,221
P50 · FY2024 · HD · contact PI
On-demand nonhormonal male contraception via ADCY10 inhibition$1,999,520
P50 · FY2023 · HD · contact PI
Comparative studies on the regulation of metabolism during sperm capacitation$705,984
R01 · FY2023 · HD
Optimization of lead candidates for an on-demand male contraceptive$689,299
R01 · FY2023 · HD
Optimization of in vivo validated ADCY10 inhibitors$395,552
P50 · FY2023 · HD · contact PI
Target Engagement$254,570
P50 · FY2023 · HD · contact PI
Administrative Core$251,221
P50 · FY2023 · HD · contact PI
Comparative studies on the regulation of metabolism during sperm capacitation$746,828
R01 · FY2022 · HD
High Throughput screen to identify "first of their kind" activators of ADCY10$569,432
R01 · FY2022 · AG · contact PI
On-Demand Pharmacological Contraception by Blocking ADCY 10$1,982,625
P50 · FY2021 · HD · contact PI
Optimization and pre-clinical evaluation of ADCY10 inhibitors$714,873
P50 · FY2021 · HD · contact PI
High Throughput screen to identify "first of their kind" activators of ADCY10$569,432
R01 · FY2021 · AG · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$475,372
R01 · FY2021 · HD
Development of regulatory domain inhibitors of ADCY10$357,881
P50 · FY2021 · HD · contact PI
Administrative Core$239,192
P50 · FY2021 · HD · contact PI
On-Demand Pharmacological Contraception by Blocking ADCY 10$1,982,625
P50 · FY2020 · HD · contact PI
Optimization and pre-clinical evaluation of ADCY10 inhibitors$714,873
P50 · FY2020 · HD · contact PI
High Throughput screen to identify "first of their kind" activators of ADCY10$588,072
R01 · FY2020 · AG · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$501,946
R01 · FY2020 · HD
Development of regulatory domain inhibitors of ADCY10$357,881
P50 · FY2020 · HD · contact PI
Administrative Core$239,192
P50 · FY2020 · HD · contact PI
On-Demand Pharmacological Contraception by Blocking ADCY 10$2,000,000
P50 · FY2019 · HD · contact PI
Optimization and pre-clinical evaluation of ADCY10 inhibitors$714,873
P50 · FY2019 · HD · contact PI
High Throughput screen to identify "first of their kind" activators of ADCY10$566,037
R01 · FY2019 · AG · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$557,490
R01 · FY2019 · HD
Development of regulatory domain inhibitors of ADCY10$357,881
P50 · FY2019 · HD · contact PI
Administrative Core$239,192
P50 · FY2019 · HD · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$485,074
R01 · FY2018 · HD
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$55,306
R01 · FY2018 · HD
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$474,312
R01 · FY2017 · HD
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2017 · GM · contact PI
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2016 · GM · contact PI
Modulating intraocular pressure to treat ocular hypotony and glaucoma$249,000
R21 · FY2016 · EY
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2015 · GM · contact PI
Modulating intraocular pressure to treat ocular hypotony and glaucoma$226,625
R21 · FY2015 · EY
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2014 · GM · contact PI
Bicarbonate regulated adenylyl cyclase$407,105
R01 · FY2013 · GM
Soluble adenylyl cyclase isoforms essential for male fertility$316,284
R01 · FY2013 · HD · contact PI
Bicarbonate regulated adenylyl cyclase$421,797
R01 · FY2012 · GM
Soluble adenylyl cyclase isoforms essential for male fertility$333,282
R01 · FY2012 · HD · contact PI
Bicarbonate regulated adenylyl cyclase$421,725
R01 · FY2011 · GM
Soluble adenylyl cyclase isoforms essential for male fertility$333,282
R01 · FY2011 · HD · contact PI
Bicarbonate regulated adenylyl cyclase$511,041
R01 · FY2010 · GM
Neuronal growth factor signaling via cAMP$363,826
R01 · FY2010 · NS · contact PI
Soluble adenylyl cyclase isoforms essential for male fertility$347,168
R01 · FY2010 · HD · contact PI
Neuronal growth factor signaling via cAMP$367,500
R01 · FY2009 · NS · contact PI
Soluble adenylyl cyclase isoforms essential for male fertility$348,600
R01 · FY2009 · HD · contact PI
Neuronal growth factor signaling via cAMP$10,110
R01 · FY2009 · NS · contact PI
Neuronal growth factor signaling via cAMP$367,500
R01 · FY2008 · NS · contact PI
A new target for malaria drug development$312,535
R01 · FY2008 · AI · contact PI
A new target for malaria drug development$368,088
R01 · FY2007 · AI · contact PI
Neuronal growth factor signaling via cAMP$367,500
R01 · FY2007 · NS · contact PI
A new target for malaria drug development$410,130
R01 · FY2006 · AI · contact PI
New target for malaria drug development$336,000
R01 · FY2005 · AI
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS$305,100
R01 · FY2004 · HD
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS$305,100
R01 · FY2003 · HD
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS$305,100
R01 · FY2002 · HD
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS$305,100
R01 · FY2001 · HD